What is the current stock price of Guided Therapeutics, Inc. (GTHP)?

As of the latest market data, Guided Therapeutics, Inc. (GTHP) is trading at $0.22. The stock has seen a loss of -9.17% today.

Does Guided Therapeutics, Inc. (GTHP) pay a dividend?

Based on current data, Guided Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Guided Therapeutics, Inc.?

The current market capitalization of Guided Therapeutics, Inc. (GTHP) is approximately unavailable.

GTHP

Guided Therapeutics, Inc.·Healthcare

0.22

9.167%(−0.02)

Market Closed

0.23

5.505%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.0752W H: $0.54

GTHP NEWS

defenseworld.net

Apr 3

Haemonetics (NYSE:HAE) vs. Guided Therapeutics (OTCMKTS:GTHP) Head to Head Review

Haemonetics (NYSE: HAE - Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, analyst recommendations and profitability. Risk and Volatility Haemonetics has a beta of 0.36,

businesswire.com

Mar 31

Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, provided several updates in conjunction with the Company's 2025 10k financial report, filed on March 30, 2026. First, preliminary analysis of the FDA clinical study data has been completed. Over 480 women participated in the multicenter trial and there we.

defenseworld.net

Mar 10

Guided Therapeutics (OTCMKTS:GTHP) Shares Down 12.7% – Time to Sell?

Guided Therapeutics Inc. (OTCMKTS:GTHP - Get Free Report)'s stock price fell 12.7% on Monday. The company traded as low as $0.2620 and last traded at $0.2620. 3,800 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 10,586 shares. The stock had previously closed at $0.30. Guided Therapeutics

Company Profile

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2021-01-08

Beta

0.75

Websitewww.guidedinc.com↗